 | • レポートコード：QYR2104Z1992 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ドラッグリポジショニングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍、中枢神経系疾患、神経変性疾患、その他）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ドラッグリポジショニングの市場動向 ・企業の競争状況、市場シェア ・ドラッグリポジショニングの種類別市場規模（腫瘍、中枢神経系疾患、神経変性疾患、その他） ・ドラッグリポジショニングの用途別市場規模（病院、外来手術センター、その他） ・ドラッグリポジショニングの北米市場規模2016-2027（アメリカ、カナダ） ・ドラッグリポジショニングのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ドラッグリポジショニングのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ドラッグリポジショニングの中南米市場規模2016-2027（メキシコ、ブラジル） ・ドラッグリポジショニングの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Astellas Pharma、Biovista、Novartis、AbbVie、Pfizer、Allergan、NuMedii） ・結論 |
Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.
Requirement of low investment of time and money in the drug development is the prime advantage of drug repurposing and majority of the drugs in pipeline of major pharmaceutical companies are thus adopt this method. Some of the factors accelerating the drug repurposing activities include sunk research cost, ready availably of bioavailability, pharmacology, toxicity profile & pharmacokinetics data, well established manufacturing protocol etc.; which are expected to drive the global drug repurposing market. There are thousands of failed molecules shelved into the drug libraries, which hold vast potential to reposition. Whereas, limited access chemical structure data of drug molecules, lack of funding etc. are some of the factors limiting the growth of global drug repurposing market.
Market Analysis and Insights: Global Drug Repurposing Market
The global Drug Repurposing market size is projected to reach US$ 30050 million by 2026, from US$ 24560 million in 2019, at a CAGR of 2.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug Repurposing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug Repurposing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug Repurposing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug Repurposing market.
Global Drug Repurposing Scope and Market Size
Drug Repurposing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug Repurposing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oncology
CNS Diseases
Neurodegenerative Diseases
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Astellas Pharma
Biovista
Novartis
AbbVie
Pfizer
Allergan
NuMedii
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Repurposing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oncology
1.2.3 CNS Diseases
1.2.4 Neurodegenerative Diseases
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drug Repurposing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drug Repurposing Market Perspective (2016-2027)
2.2 Drug Repurposing Growth Trends by Regions
2.2.1 Drug Repurposing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drug Repurposing Historic Market Share by Regions (2016-2021)
2.2.3 Drug Repurposing Forecasted Market Size by Regions (2022-2027)
2.3 Drug Repurposing Industry Dynamic
2.3.1 Drug Repurposing Market Trends
2.3.2 Drug Repurposing Market Drivers
2.3.3 Drug Repurposing Market Challenges
2.3.4 Drug Repurposing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Repurposing Players by Revenue
3.1.1 Global Top Drug Repurposing Players by Revenue (2016-2021)
3.1.2 Global Drug Repurposing Revenue Market Share by Players (2016-2021)
3.2 Global Drug Repurposing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drug Repurposing Revenue
3.4 Global Drug Repurposing Market Concentration Ratio
3.4.1 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Repurposing Revenue in 2020
3.5 Drug Repurposing Key Players Head office and Area Served
3.6 Key Players Drug Repurposing Product Solution and Service
3.7 Date of Enter into Drug Repurposing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Repurposing Breakdown Data by Type
4.1 Global Drug Repurposing Historic Market Size by Type (2016-2021)
4.2 Global Drug Repurposing Forecasted Market Size by Type (2022-2027)
5 Drug Repurposing Breakdown Data by Application
5.1 Global Drug Repurposing Historic Market Size by Application (2016-2021)
5.2 Global Drug Repurposing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Drug Repurposing Market Size (2016-2027)
6.2 North America Drug Repurposing Market Size by Type
6.2.1 North America Drug Repurposing Market Size by Type (2016-2021)
6.2.2 North America Drug Repurposing Market Size by Type (2022-2027)
6.2.3 North America Drug Repurposing Market Size by Type (2016-2027)
6.3 North America Drug Repurposing Market Size by Application
6.3.1 North America Drug Repurposing Market Size by Application (2016-2021)
6.3.2 North America Drug Repurposing Market Size by Application (2022-2027)
6.3.3 North America Drug Repurposing Market Size by Application (2016-2027)
6.4 North America Drug Repurposing Market Size by Country
6.4.1 North America Drug Repurposing Market Size by Country (2016-2021)
6.4.2 North America Drug Repurposing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Drug Repurposing Market Size (2016-2027)
7.2 Europe Drug Repurposing Market Size by Type
7.2.1 Europe Drug Repurposing Market Size by Type (2016-2021)
7.2.2 Europe Drug Repurposing Market Size by Type (2022-2027)
7.2.3 Europe Drug Repurposing Market Size by Type (2016-2027)
7.3 Europe Drug Repurposing Market Size by Application
7.3.1 Europe Drug Repurposing Market Size by Application (2016-2021)
7.3.2 Europe Drug Repurposing Market Size by Application (2022-2027)
7.3.3 Europe Drug Repurposing Market Size by Application (2016-2027)
7.4 Europe Drug Repurposing Market Size by Country
7.4.1 Europe Drug Repurposing Market Size by Country (2016-2021)
7.4.2 Europe Drug Repurposing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Drug Repurposing Market Size (2016-2027)
8.2 Asia-Pacific Drug Repurposing Market Size by Type
8.2.1 Asia-Pacific Drug Repurposing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drug Repurposing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drug Repurposing Market Size by Type (2016-2027)
8.3 Asia-Pacific Drug Repurposing Market Size by Application
8.3.1 Asia-Pacific Drug Repurposing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drug Repurposing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drug Repurposing Market Size by Application (2016-2027)
8.4 Asia-Pacific Drug Repurposing Market Size by Region
8.4.1 Asia-Pacific Drug Repurposing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drug Repurposing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drug Repurposing Market Size (2016-2027)
9.2 Latin America Drug Repurposing Market Size by Type
9.2.1 Latin America Drug Repurposing Market Size by Type (2016-2021)
9.2.2 Latin America Drug Repurposing Market Size by Type (2022-2027)
9.2.3 Latin America Drug Repurposing Market Size by Type (2016-2027)
9.3 Latin America Drug Repurposing Market Size by Application
9.3.1 Latin America Drug Repurposing Market Size by Application (2016-2021)
9.3.2 Latin America Drug Repurposing Market Size by Application (2022-2027)
9.3.3 Latin America Drug Repurposing Market Size by Application (2016-2027)
9.4 Latin America Drug Repurposing Market Size by Country
9.4.1 Latin America Drug Repurposing Market Size by Country (2016-2021)
9.4.2 Latin America Drug Repurposing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Repurposing Market Size (2016-2027)
10.2 Middle East & Africa Drug Repurposing Market Size by Type
10.2.1 Middle East & Africa Drug Repurposing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drug Repurposing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drug Repurposing Market Size by Type (2016-2027)
10.3 Middle East & Africa Drug Repurposing Market Size by Application
10.3.1 Middle East & Africa Drug Repurposing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drug Repurposing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drug Repurposing Market Size by Application (2016-2027)
10.4 Middle East & Africa Drug Repurposing Market Size by Country
10.4.1 Middle East & Africa Drug Repurposing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drug Repurposing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Drug Repurposing Introduction
11.1.4 Astellas Pharma Revenue in Drug Repurposing Business (2016-2021)
11.1.5 Astellas Pharma Recent Development
11.2 Biovista
11.2.1 Biovista Company Details
11.2.2 Biovista Business Overview
11.2.3 Biovista Drug Repurposing Introduction
11.2.4 Biovista Revenue in Drug Repurposing Business (2016-2021)
11.2.5 Biovista Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Drug Repurposing Introduction
11.3.4 Novartis Revenue in Drug Repurposing Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Drug Repurposing Introduction
11.4.4 AbbVie Revenue in Drug Repurposing Business (2016-2021)
11.4.5 AbbVie Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Drug Repurposing Introduction
11.5.4 Pfizer Revenue in Drug Repurposing Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Drug Repurposing Introduction
11.6.4 Allergan Revenue in Drug Repurposing Business (2016-2021)
11.6.5 Allergan Recent Development
11.7 NuMedii
11.7.1 NuMedii Company Details
11.7.2 NuMedii Business Overview
11.7.3 NuMedii Drug Repurposing Introduction
11.7.4 NuMedii Revenue in Drug Repurposing Business (2016-2021)
11.7.5 NuMedii Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Drug Repurposing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oncology
Table 3. Key Players of CNS Diseases
Table 4. Key Players of Neurodegenerative Diseases
Table 5. Key Players of Others
Table 6. Global Drug Repurposing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Drug Repurposing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Drug Repurposing Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Drug Repurposing Market Share by Regions (2016-2021)
Table 10. Global Drug Repurposing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Drug Repurposing Market Share by Regions (2022-2027)
Table 12. Drug Repurposing Market Trends
Table 13. Drug Repurposing Market Drivers
Table 14. Drug Repurposing Market Challenges
Table 15. Drug Repurposing Market Restraints
Table 16. Global Drug Repurposing Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Drug Repurposing Market Share by Players (2016-2021)
Table 18. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Repurposing as of 2020)
Table 19. Ranking of Global Top Drug Repurposing Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Drug Repurposing Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Drug Repurposing Product Solution and Service
Table 23. Date of Enter into Drug Repurposing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drug Repurposing Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Drug Repurposing Revenue Market Share by Type (2016-2021)
Table 27. Global Drug Repurposing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Drug Repurposing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Drug Repurposing Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Drug Repurposing Revenue Market Share by Application (2016-2021)
Table 31. Global Drug Repurposing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Drug Repurposing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Drug Repurposing Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Drug Repurposing Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Drug Repurposing Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Drug Repurposing Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Drug Repurposing Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Drug Repurposing Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Drug Repurposing Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Drug Repurposing Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Drug Repurposing Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Drug Repurposing Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Drug Repurposing Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Drug Repurposing Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Drug Repurposing Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Drug Repurposing Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Drug Repurposing Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Drug Repurposing Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Drug Repurposing Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Drug Repurposing Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Drug Repurposing Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Drug Repurposing Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Drug Repurposing Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Drug Repurposing Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Drug Repurposing Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Drug Repurposing Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Drug Repurposing Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Drug Repurposing Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Drug Repurposing Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Drug Repurposing Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Drug Repurposing Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Drug Repurposing Market Size by Country (2022-2027) & (US$ Million)
Table 63. Astellas Pharma Company Details
Table 64. Astellas Pharma Business Overview
Table 65. Astellas Pharma Drug Repurposing Product
Table 66. Astellas Pharma Revenue in Drug Repurposing Business (2016-2021) & (US$ Million)
Table 67. Astellas Pharma Recent Development
Table 68. Biovista Company Details
Table 69. Biovista Business Overview
Table 70. Biovista Drug Repurposing Product
Table 71. Biovista Revenue in Drug Repurposing Business (2016-2021) & (US$ Million)
Table 72. Biovista Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Drug Repurposing Product
Table 76. Novartis Revenue in Drug Repurposing Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. AbbVie Company Details
Table 79. AbbVie Business Overview
Table 80. AbbVie Drug Repurposing Product
Table 81. AbbVie Revenue in Drug Repurposing Business (2016-2021) & (US$ Million)
Table 82. AbbVie Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Drug Repurposing Product
Table 86. Pfizer Revenue in Drug Repurposing Business (2016-2021) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Allergan Company Details
Table 89. Allergan Business Overview
Table 90. Allergan Drug Repurposing Product
Table 91. Allergan Revenue in Drug Repurposing Business (2016-2021) & (US$ Million)
Table 92. Allergan Recent Development
Table 93. NuMedii Company Details
Table 94. NuMedii Business Overview
Table 95. NuMedii Drug Repurposing Product
Table 96. NuMedii Revenue in Drug Repurposing Business (2016-2021) & (US$ Million)
Table 97. NuMedii Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Repurposing Market Share by Type: 2020 VS 2027
Figure 2. Oncology Features
Figure 3. CNS Diseases Features
Figure 4. Neurodegenerative Diseases Features
Figure 5. Others Features
Figure 6. Global Drug Repurposing Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Drug Repurposing Report Years Considered
Figure 11. Global Drug Repurposing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Drug Repurposing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Drug Repurposing Market Share by Regions: 2020 VS 2027
Figure 14. Global Drug Repurposing Market Share by Regions (2022-2027)
Figure 15. Global Drug Repurposing Market Share by Players in 2020
Figure 16. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Repurposing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Drug Repurposing Revenue in 2020
Figure 18. Global Drug Repurposing Revenue Market Share by Type (2016-2021)
Figure 19. Global Drug Repurposing Revenue Market Share by Type (2022-2027)
Figure 20. North America Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Drug Repurposing Market Share by Type (2016-2027)
Figure 22. North America Drug Repurposing Market Share by Application (2016-2027)
Figure 23. North America Drug Repurposing Market Share by Country (2016-2027)
Figure 24. United States Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Drug Repurposing Market Share by Type (2016-2027)
Figure 28. Europe Drug Repurposing Market Share by Application (2016-2027)
Figure 29. Europe Drug Repurposing Market Share by Country (2016-2027)
Figure 30. Germany Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Drug Repurposing Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Drug Repurposing Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Drug Repurposing Market Share by Region (2016-2027)
Figure 40. China Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Drug Repurposing Market Share by Type (2016-2027)
Figure 48. Latin America Drug Repurposing Market Share by Application (2016-2027)
Figure 49. Latin America Drug Repurposing Market Share by Country (2016-2027)
Figure 50. Mexico Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Drug Repurposing Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Drug Repurposing Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Drug Repurposing Market Share by Country (2016-2027)
Figure 56. Turkey Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Drug Repurposing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Astellas Pharma Revenue Growth Rate in Drug Repurposing Business (2016-2021)
Figure 60. Biovista Revenue Growth Rate in Drug Repurposing Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Drug Repurposing Business (2016-2021)
Figure 62. AbbVie Revenue Growth Rate in Drug Repurposing Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Drug Repurposing Business (2016-2021)
Figure 64. Allergan Revenue Growth Rate in Drug Repurposing Business (2016-2021)
Figure 65. NuMedii Revenue Growth Rate in Drug Repurposing Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の神経変性疾患治療薬市場規模・現状・予測（2021年-2027年） Neurodegenerative disease is caused by the loss of neurons and/or their myelin sheath, which worsens over time and becomes dysfunctional. Market Analysis and Insights: Global Neurodegenerative Diseases Drug Market The global Neurodegenerative Diseases Drug market size is projected to reach US$ XX m…- 世界の鎮痛剤デリバリー市場規模・現状・予測（2021年-2027年） Drug delivery refers to approaches, formulations, technologies and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices o…
- 世界の鎮痛剤デリバリー市場規模・現状・予測（2021年-2027年） Drug delivery refers to approaches, formulations, technologies and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices o…
- 世界のドラッグリポジショニング市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Repositioning Market The global Drug Repositioning market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes…
- 世界の薬物転送技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Transport Technology Market The global Drug Transport Technology market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…